|
Match
|
Document |
Document Title |
Score |
|
|
EP1894138A1 |
METHOD
|
1000 |
|
|
US20090134211 |
Method
The present invention relates to a method for the provision of clinical trial products in the context of clinical trials.
|
1000 |
|
|
D620976 |
Binder
|
1000 |
|
|
WO/2006/131544A1 |
METHOD
The present invention relates to a method for the provision of clinical trial products in the context of clinical trials.
|
1000 |
|
|
WO/1996/017607A1 |
METHOD OF PRODUCING A PANTOPRAZOL LYOPHILISATE
Disclosed is a method of producing a lyophilisate of pantoprazol sodium sesquihydrate, characterised by the lyophilisation of aqueous solutions of pantoprazol sodium sesquihydrate in the presence...
|
1000 |
|
|
EP1037607A1 |
NOVEL SUPPOSITORY FORM COMPRISING AN ACID-LABILE ACTIVE COMPOUND
Abstract not available for EP1037607 Abstract of corresponding document: WO9929320 Novel administration form for acid-labile active compounds are described. The novel administration forms have no...
|
800 |
|
|
EP1105105A1 |
ORAL ADMINISTRATION FORM FOR PYRIDIN-2-YLMETHYLSULFINYL-1H-BENZIMIDAZOLES
Abstract not available for EP1105105
|
800 |
|
|
EP1037634B1 |
ORAL ADMINISTRATION FORM COMPRISING A PROTON PUMP INHIBITOR (E.G.PANTOPRAZOLE)
|
800 |
|
|
EP1339430B1 |
FREEZE-DRIED PANTOPRAZOLE PREPARATION AND PANTOPRAZOLE INJECTION
|
800 |
|
|
EP1037634A1 |
Title is not available
|
800 |
|
|
EP1341524A2 |
PHARMACEUTICAL PREPARATION IN THE FORM OF A PASTE COMPRISING AN ACID-LABILE ACTIVE INGREDIENT
|
800 |
|
|
EP1105105B1 |
ORAL ADMINISTRATION FORM FOR PYRIDIN-2-YLMETHYLSULFINYL-1H-BENZIMIDAZOLES
Abstract not available for EP1105105
|
800 |
|
|
EP1762249A2 |
Freeze-dried pantoprazole preparation and pantoprazole injection
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
|
800 |
|
|
EP1187601B1 |
NOVEL PREPARATION AND ADMINISTRATION FORM COMPRISING AN ACID-LABILE PROTON PUMP INHIBITOR
Abstract not available for EP1187601 Abstract of corresponding document: EP1616562 Novel administration forms and preparations for acid-labile active compounds are described. The novel...
|
800 |
|
|
EP0519365A1 |
Compositions for oral administration containing pantoprazole.
The invention relates to compositions for oral administration containing pantoprazole which consist of a core, of an intermediate layer and of an enteric outer layer.
|
800 |
|
|
EP0589981B1 |
ORAL-ADMINISTRATION FORMS OF A MEDICAMENT CONTAINING PANTOPRAZOL
Abstract not available for EP0589981 Abstract of corresponding document: US5997903 PCT No. PCT/EP92/01341 Sec. 371 Date Dec. 17, 1993 Sec. 102(e) Date Dec. 17, 1993 PCT Filed Jun. 13, 1992 PCT...
|
800 |
|
|
EP1037607B1 |
NOVEL SUPPOSITORY FORM COMPRISING AN ACID-LABILE ACTIVE COMPOUND
Abstract not available for EP1037607 Abstract of corresponding document: WO9929320 Novel administration form for acid-labile active compounds are described. The novel administration forms have no...
|
800 |
|
|
EP1339430A1 |
FREEZE-DRIED PANTOPRAZOLE PREPARATION AND PANTOPRAZOLE INJECTION
|
800 |
|
|
EP0589981A1 |
ORAL-ADMINISTRATION FORMS OF A MEDICAMENT CONTAINING PANTOPRAZOL.
Abstract not available for EP0589981 Abstract of corresponding document: US5997903 PCT No. PCT/EP92/01341 Sec. 371 Date Dec. 17, 1993 Sec. 102(e) Date Dec. 17, 1993 PCT Filed Jun. 13, 1992 PCT...
|
800 |
|
|
EP1525882A1 |
Administration form comprising an acid-labile active compound
Abstract not available
|
800 |
|
|
EP1341523A1 |
PHARMACEUTICAL PREPARATION IN THE FORM OF A SUSPENSION COMPRISING AN ACID-LABILE ACTIVE INGREDIENT
|
800 |
|
|
EP1187601A1 |
NOVEL PREPARATION AND ADMINISTRATION FORM COMPRISING AN ACID-LABILE PROTON PUMP INHIBITOR
Abstract not available for EP1187601 Abstract of corresponding document: EP1616562 Novel administration forms and preparations for acid-labile active compounds are described. The novel...
|
800 |
|
|
US20030003058 |
Freeze-dried pantoprazole preparation and pantoprazole injection
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
|
800 |
|
|
US20040220228 |
Freeze-dried pantoprazole preparation and pantoprazole injection
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
|
800 |
|
|
US20040052832 |
Pharmaceutical preparation in the form of a supension comprising an acid-labile active ingredient
The present invention relates to the field of pharmaceutical technology and describes a novel pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient, in...
|
800 |
|
|
US20080069882 |
Novel preparation and administration form comprising an acid-labile active compound
Novel administration forms and preparation for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being present...
|
800 |
|
|
US20060263426 |
Oral administration form for pyridin-2-ylmethysulfinyl-1h-bezimidazoles
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
|
800 |
|
|
US20020090397 |
Novel suppository form comprising an acid-labile active compound
Acid-labile active compounds are prepared in suppository form, particularly for rectal administration.
|
800 |
|
|
US20060127477 |
Novel preparation and administration form comprising an acid-labile active compound
Novel administration forms and preparation for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being present...
|
800 |
|
|
US20020025342 |
Novel administration form comprising an acid-labile active compound
Novel administration form for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.
|
800 |
|
|
US20080226712 |
Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
|
800 |
|
|
US20040101558 |
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
The present invention relates to the field of pharmaceutical technology and describes a pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient, in particular...
|
800 |
|
|
US20040022854 |
Novel administration form comprising an acid-labile active compound
Novel administration form for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.
|
800 |
|
|
US20090093522 |
Freeze-dried pantoprazole preparation and pantoprazole injection
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
|
800 |
|
|
6068856 |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
An oral pharmaceutical composition of pantoprazole in pellet or tablet form, wherein the pantoprazole is at least partly in slow-release form, is distinguished, on combined administration with an...
|
800 |
|
|
7402321 |
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
|
800 |
|
|
6132768 |
Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
An oral pharmaceutical composition of a reversible proton pump inhibitor in pellet or tablet form, wherein the reversible proton pump inhibitor is at least partly in slow-release form, is...
|
800 |
|
|
6780881 |
Freeze-dried pantoprazole preparation and pantoprazole injection
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
|
800 |
|
|
7041313 |
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
|
800 |
|
|
6569453 |
Administration form comprising an acid-labile active compound
An administration form for acid-labile active compounds are described. The administration forms have no enteric layers and are suitable for oral administration.
|
800 |
|
|
7357943 |
Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
The present invention relates to the field of pharmaceutical technology and describes a novel pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient, in...
|
800 |
|
|
5997903 |
Oral-administration forms of a medicament containing pantoprazol
The invention relates to oral presentation forms for pantoprazole, which consist of a core, an intermediate layer and an outer layer which is resistant to gastric juice.
|
800 |
|
|
6328993 |
Oral administration form for an acid liable active proton pump inhibitor
Novel administration form for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.
|
800 |
|
|
6274173 |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
An oral pharmaceutical composition comprises an acid-labile irreversible proton pump inhibitor in pellet or tablet form, wherein the irreversible proton pump inhibitor is at least partly in...
|
800 |
|
|
5945124 |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
An oral pharmaceutical composition of pantoprazole in pellet or tablet form, wherein the pantoprazole is at least partly in slow-release form, is distinguished, on combined administration with an...
|
800 |
|
|
6884437 |
Administration form comprising an acid-labile active compound
Novel administration forms for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.
|
800 |
|
|
6607742 |
Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibitor in a solvent solution of a sterol and polymer
Acid-labile active compounds are prepared in suppository form, particularly for rectal administration.
|
800 |
|
|
6383510 |
Suppository form comprising an acid-labile active compound
Acid-labile active compounds are prepared in suppository form, particularly for rectal administration.
|
800 |
|
|
7351723 |
Freeze-dried pantoprazole preparation and pantoprazole injection
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
|
800 |
|
|
7785630 |
Preparation and administration form comprising an acid-labile active compound
Novel administration forms and preparation for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being present...
|
800 |